Financial results - EMBRYOMED SRL

Financial Summary - Embryomed Srl
Unique identification code: 33834495
Registration number: J23/3407/2014
Nace: 8622
Sales - Ron
84.456
Net Profit - Ron
43.946
Employee
1
The most important financial indicators for the company Embryomed Srl - Unique Identification Number 33834495: sales in 2023 was 84.456 euro, registering a net profit of 43.946 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Embryomed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 2.348 21.119 27.372 36.460 40.347 39.542 68.506 91.594 94.120 84.456
Total Income - EUR 2.348 21.119 27.372 36.460 40.347 39.542 68.506 91.594 94.120 84.456
Total Expenses - EUR 710 9.877 37.504 26.589 33.846 30.979 30.147 31.687 33.489 39.708
Gross Profit/Loss - EUR 1.638 11.243 -10.132 9.870 6.502 8.563 38.359 59.907 60.631 44.749
Net Profit/Loss - EUR 1.568 10.609 -10.680 7.187 6.098 8.168 37.674 59.105 59.830 43.946
Employees 0 1 1 1 0 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -10.0%, from 94.120 euro in the year 2022, to 84.456 euro in 2023. The Net Profit decreased by -15.703 euro, from 59.830 euro in 2022, to 43.946 in the last year.

Check the financial reports for the company - Embryomed Srl

Rating financiar

Financial Rating -
Embryomed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Embryomed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Embryomed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Embryomed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Embryomed Srl - CUI 33834495

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 162 107 31.003 30.428 33.200 27.827 21.878 17.300 10.080 8.799
Current Assets 1.521 12.893 4.618 5.421 4.511 7.010 54.841 109.408 147.598 137.032
Inventories 0 0 0 0 1.530 32 686 671 673 0
Receivables 0 1.339 2.004 4.460 1.844 1.808 6.586 5.004 1.436 1.492
Cash 1.521 11.554 2.615 961 1.137 5.170 47.569 103.732 145.489 135.540
Shareholders Funds 1.612 12.235 1.430 8.593 14.534 22.420 37.724 95.992 121.191 103.099
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 71 766 34.191 27.256 23.176 12.417 38.995 30.716 36.487 42.731
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 137.032 euro in 2023 which includes Inventories of 0 euro, Receivables of 1.492 euro and cash availability of 135.540 euro.
The company's Equity was valued at 103.099 euro, while total Liabilities amounted to 42.731 euro. Equity decreased by -17.724 euro, from 121.191 euro in 2022, to 103.099 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Embryomed Srl

Comments - Embryomed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.